Wells Fargo & Company Begins Coverage on Heartflow (NASDAQ:HTFL)

Analysts at Wells Fargo & Company initiated coverage on shares of Heartflow (NASDAQ:HTFL) in a note issued to investors on Wednesday, Marketbeat.com reports. The brokerage set an “overweight” rating and a $38.00 price target on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 22.19% from the company’s current price.

Other research analysts have also issued reports about the company. JPMorgan Chase & Co. lifted their price objective on Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Canaccord Genuity Group lifted their price target on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Stifel Nicolaus upped their target price on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $38.50.

Heartflow Stock Performance

HTFL opened at $31.10 on Wednesday. Heartflow has a twelve month low of $25.38 and a twelve month high of $41.22. The business’s fifty day moving average price is $30.67. The firm has a market capitalization of $2.65 billion and a PE ratio of -17.18.

Insider Transactions at Heartflow

In related news, Director Jeffrey C. Lightcap bought 40,000 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was acquired at an average cost of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares in the company, valued at $1,053,600. This trade represents a ? increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Hedge Funds Weigh In On Heartflow

Large investors have recently bought and sold shares of the stock. TFC Financial Management Inc. bought a new stake in shares of Heartflow in the third quarter worth about $40,000. Legal & General Group Plc bought a new stake in shares of Heartflow in the 3rd quarter worth approximately $59,000. Y Intercept Hong Kong Ltd purchased a new position in shares of Heartflow during the third quarter valued at approximately $234,000. Legato Capital Management LLC bought a new position in shares of Heartflow during the third quarter valued at approximately $243,000. Finally, Sandia Investment Management LP purchased a new stake in Heartflow in the third quarter worth $252,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.